A Phase 2, Open-Label Study To Evaluate The Efficacy And Safety Of Lenalidomide In Combination With Cetuximab In Pretreated Subjects With K-Ras Mutant Metastatic Colorectal Cancer.
Phase of Trial: Phase II
Latest Information Update: 03 May 2016
At a glance
- Drugs Cetuximab; Lenalidomide
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 17 Mar 2012 This trial has been completed in Germany, Belgium, Sweden, Italy.
- 11 Feb 2011 Planned end date changed from 1 Dec 2017 to 1 Jan 2011 as reported by ClinicalTrials.gov.